Rigel Pharmaceuticals RIGL Debt Principal Outstanding, Net Of Unamortized Debt Issuance Costs

Debt Principal Outstanding, Net Of Unamortized Debt Issuance Costs at other companies

UMH

UMH PropertiesUMH

6.5%-0.3pp

Upbound Group, Inc.UPBD

$995.25M-8.7%

AmetekAME

$2.7M-33.4%

Main Street CapitalMAIN

$13.05M+11.8%

Warrior Met CoalHCC

$2.1M-23.8%

Ondas, Inc. ONDS

$35.21K-99.7%

Other financials

Income statement

See full

Revenue$58.8M+10.3%

Gross profit$54.2M+10.8%

Operating income$11.9M-7.0%

Net income$8.7M-24.4%

EPS (diluted)$0.44-30.2%

Balance sheet

See full

Cash & equivalents$24.5M-46.6%

Total debt$68.4M+5,079%

Total equity$399.9M+2,054%

Total assets$504.6M+187%

Cash flow

See full

Operating cash flow$2.7M+405%

CapEx$73.0K—

Free cash flow-$22.0M—

Valuation

See full

Market cap$684.39M+102%

Enterprise value$728.29M+148%

P/E1.9×-7.2×

P/S2.3×+0.6×

Profitability

See full

Gross margin93.4%+3.7pp

Operating margin41.6%+19.9pp

Net margin121.5%+103pp

FCF margin-61.7%—

Returns & leverage

See full

Return on equity174.1%—

Debt / equity0.2×+0.1×

Current ratio2.6×+0.4×

Where this comes from

Reported directly by Rigel Pharmaceuticals in its filing.

Tagged under the XBRL concept rigl:DebtPrincipalOutstandingNetOfUnamortizedDebtIssuanceCosts.

The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rigel Pharmaceuticals's debt principal outstanding, net of unamortized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rigel Pharmaceuticals's debt principal outstanding, net of unamortized debt issuance costs?: Rigel Pharmaceuticals (RIGL) reported debt principal outstanding, net of unamortized debt issuance costs of $44.86M in Q1 2026.
What does debt principal outstanding, net of unamortized debt issuance costs mean?: This metric reflects the total face value of outstanding debt obligations minus the remaining unamortized costs associated with issuing that debt. It provides a clear view of the actual principal amount the company is obligated to repay to creditors. Investors use this to evaluate the company's total leverage and the net carrying value of its debt instruments.